The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2019

Filed:

May. 06, 2016
Applicants:

Luzitin, S.a., Coimbra, PT;

Universidade DE Coimbra, Coimbra, PT;

Assignees:

LUZITIN, S.A., Coimbra, PT;

UNIVERSIDADE DE COIMBRA, Coimbra, PT;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 41/00 (2006.01); A61K 49/10 (2006.01); A61B 5/00 (2006.01); C07D 487/22 (2006.01); A61B 5/055 (2006.01); A61N 5/06 (2006.01);
U.S. Cl.
CPC ...
C07D 487/22 (2013.01); A61B 5/0095 (2013.01); A61B 5/055 (2013.01); A61K 41/0028 (2013.01); A61K 41/0071 (2013.01); A61K 49/106 (2013.01); A61N 5/062 (2013.01); C07B 2200/07 (2013.01); C07B 2200/09 (2013.01);
Abstract

The present invention relates to carboxamide halogenated porphyrin derivatives, in particular bacteriochlorin or chlorin, of formula (I) use of the same or a pharmaceutically acceptable salt thereof in photodynamic therapy, where the derivatives are able to detect and exhibit the presence of hyperproliferative disorders and, in the presence of an adequate lighting, to treat the same. The present invention also describes a pharmaceutical composition having the carboxamide halogenated porphyrin derivatives, in particular bacteria-chlorin or chlorin, of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of cancer and/or microbial and/or viral infections, in humans or animals.


Find Patent Forward Citations

Loading…